|
|
|
| Ultrasound imaging characteristics analysis of benign and malignant thyroid nodules |
| LI Bing WU Qi SUN Shengrong |
| Department of Breast and Thyroid Surgery, Renmin Hosptial of Wuhan University, Hubei Province, Wuhan 430060, China |
|
|
|
Abstract Objective To analyze ultrasound imaging characteristics of thyroid nodules with the relative importance of these features in predicting risk for malignancy. Methods 933 patients underwent thyroid ultrasound imaging and thyroid nodule resection from June 2012 to September 2014 in Renmin Hosptial of Wuhan University were retrospectively analyzed. 1362 resected nodules were divided into benign group (n=1022) and thyroid cancer group (n=340) according to the histopathological examination results. Ultrasound results of each nodule were analyzed, the difference between two groups was compared. Risk factors of thyroid cancer screening were analyzed by Logistic regression. Results Ultrasound nodule characteristics of tumor size, boundary, calcification type, aspect ratio, blood flow signal, echo image and cervical lymph node enlargement and other imaging characteristics between benign group and thyroid cancer group were compared, with statistical differences (P ＜ 0.05). For hypoechoic nodules following four ultrasound nodule characteristics were considered to be the only findings associated with the risk of thyroid cancer: microcalcifications (OR=27.954, 95%CI=18.119-43.128, P < 0.01), central vascularity (OR=5.841, 95%CI=4.162-8.197, P < 0.01), ill defined or spiculated margins (OR=3.034, 95%CI=2.227-4.135, P < 0.01) and cervical lymphadenopathy (OR=22.981, 95%CI=13.045-40.483, P < 0.01). Grade Ⅰ was defined as none of abnormal ultrasound imaging characteristic and the risk of cancer was less than 20%. Grade Ⅱ was defined as 1 characteristic was used as an indication for ultrasound except microcalcifications, the risk of cancer was 20%-<50%.Grade Ⅲ was defined as 2 characteristics were required for ultrasound imaging included only had microcalcifications, the risk of cancer was 50%-80%. And grade Ⅳ was defined as 3 or more suggestive ultrasound characteristics were contained, the risk of cancer was more than 80%. Conclusion Thyroid ultrasound imaging can be used to identify patients who have a low risk of cancer to reduce unnecessary and excessive treatment and biopsy.
|
|
|
|
|
|
[1] Chen W，Zheng R，Zhang S，et al. Report of incidence and mortality in China cancer registries，2009 [J]. Chin J Cancer Res，2013，25（1）：10-21.
[2] Ezzat S，Sarti DA，Cain DR，et al. Thyroid incidentalomas. Prevalence by palpation and ultrasonography [J]. Arch Intern Med，1994，154（16）：1838-1840.
[3] Tan GH，Gharib H. Thyroid incidentalomas：management approaches to nonpalpable nodules discovered incidentally on thyroid imaging [J]. Ann Intern Med，1997，126（3）：226-231.
[4] Anderson JB，Webb AJ. Fine-needle aspiration biopsy and the diagnosis of thyroid cancer [J]. Br J Surg，1987，74（4）：292-296.
[5] Sabel MS，Haque D，Velasco JM，et al. Use of ultrasound-guided fine needle aspiration biopsy in the management of thyroid disease [J]. Am Surg，1998，64（8）：738-742.
[6] Frates MC，Benson CB，Doubilet PM，et al. Prevalence and distribution of carcinoma in patients with solitary and multiple thyroid nodules on sonography [J]. Clin Endocrinol Metab，2006，91（9）：3411-3417.
[7] Siegel R，Ma J，Zou Z，et al. Cancer statistics，2014 [J]. CA Cancer J Clin，2014，64（1）：9-29.
[8] Maia FF，Matos PS，Silva BP，et al. Role of ultrasound，clinical and scintigraphyc parameters to predict malignancy in thyroid nodule [J]. Head Neck Oncol，2011，3：17.
[9] Cakir B，Aydin C，Korukluoglu B，et al. Diagnostic value of elastosonographically determined strain index in the differential diagnosis of benign and malignant thyroid nodules [J]. Endocrine，2011，39（1）：89-98.
[10] Iannuccilli JD，Cronan JJ，Monchik JM. Risk for malignancy of thyroid nodules as assessed by sonographic criteria：the need for biopsy [J]. Ultrasound Med，2004，23（11）：1455-1464.
[11] Baier ND，Hahn PF，Gervais DA，et al. Fine-needle aspiration biopsy of thyroid nodules：experience in a cohort of 944 patients [J]. Am J Roentgenol，2009，193（4）：1175-1179.
[12] Gerschpacher M，Gobl C，Anderwald C，et al. Thyrotropin serum concentrations in patients with papillary thyroid microcancers [J]. Thyroid，2010，20（4）：389-392.
[13] Frates MC，Benson CB，Charboneau JW，et al. Management of thyroid nodules detected at US：society of radiologists in ultrasound consensus conference statement [J]. Ultrasound Q，2006，22（4）：231-240.
[14] Hoang JK，Lee WK，Lee M，et al. US Features of thyroid malignancy：pearls and pitfalls [J]. Radiographics，2007， 27（3）：847-865.
[15] Hegedus L. Clinical practice. The thyroid nodule [J]. N Engl J Med，2004，351（17）：1764-1771.
[16] Solbiati L，Osti V，Cova L，et al. Ultrasound of thyroid，parathyroid glands and neck lymph nodes [J]. Eur Radiol，2001，11（12）：2411-2424.
[17] González-González A，Mate Valdezate A，Parra Arroyo A，et al. Diagnostic efficiency of sonographic findings of thyroid nodules in the detection of malignancy [J]. Endocrinol Nutr，2010，57（6）：240-244.
[18] Chen K，Chen C，Wu M，et al. Computerized detection and quantification of microcalcifications in thyroid nodules [J]. Ultrasound Med Biol，2011，37（6）：870-878.
[19] Moon HJ，Kwak JY，Kim MJ，et al. Can vascularity at power Doppler US help predict thyroid malignancy? [J]. Radiology，2010，255（1）：260-269.
[20] Ozkan Z，Akyigit A，Sakallioglu O，et al. Diagnostic challenge in papillary thyroid carcinoma with cervical lymphadenopathy，metastasis，or tuberculous lymphadenitis [J]. Craniofac Surg，2013，24（6）：2200-2203.
[21] Cooper DS，Doherty GM，Haugen BR，et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer [J]. Thyroid，2009，19（11）：1167-1214.
[22] Hay ID，Bergstralh EJ，Goellner JR，et al. Predicting outcome in papillary thyroid carcinoma：development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989 [J]. Surgery，1993，114（6）：1050-1058. |
|
|
|
